“Biomedical research is in a position now where you have a couple of world superpowers—the US, China, and Europe—all vying for the same or similar pool of resources,” says Matthew Bailey, president of the National Association for Biomedical Research in Washington. About 60% of the 30,000 monkeys imported into the US were from China before the pandemic, he says, and the suspension of exports “has just created an incredible amount of uncertainty about the supply chain."

Read the full article here: https://www.bloomberg.com/news/articles/2022-09-28/research-monkey-shortage-boosts-china-s-vaccine-development?leadSource=uverify%20wall